282 related articles for article (PubMed ID: 29702606)
1. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
[TBL] [Abstract][Full Text] [Related]
2. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.
Baumert B; Sobuś A; Gołąb-Janowska M; Ulańczyk Z; Paczkowska E; Łuczkowska K; Zawiślak A; Milczarek S; Osękowska B; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041109
[TBL] [Abstract][Full Text] [Related]
3. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
[No Abstract] [Full Text] [Related]
4. Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.
Baumert B; Sobuś A; Gołąb-Janowska M; Paczkowska E; Łuczkowska K; Rogińska D; Zawiślak A; Milczarek S; Osękowska B; Pawlukowska W; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
Cells; 2020 Aug; 9(8):. PubMed ID: 32752182
[TBL] [Abstract][Full Text] [Related]
5. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Sobuś A; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Paczkowska E; Rotter I; Nowacki P; Machaliński B
Stem Cells Int; 2019; 2019():7213854. PubMed ID: 31281384
[TBL] [Abstract][Full Text] [Related]
6. Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients.
Sobuś A; Baumert B; Pawlukowska W; Gołąb-Janowska M; Paczkowska E; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Safranow K; Rotter I; Nowacki P; Machaliński B
Stem Cells Int; 2020; 2020():8888271. PubMed ID: 33381192
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
8. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
9. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
11. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction.
Baumert B; Przybycień K; Paczkowska E; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Peregud-Pogorzelska M; Machaliński B
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284593
[TBL] [Abstract][Full Text] [Related]
12. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
15. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.
Martinez HR; Gonzalez-Garza MT; Moreno-Cuevas JE; Caro E; Gutierrez-Jimenez E; Segura JJ
Cytotherapy; 2009; 11(1):26-34. PubMed ID: 19191058
[TBL] [Abstract][Full Text] [Related]
16. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
18. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
[TBL] [Abstract][Full Text] [Related]
19. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients.
Deepa P; Shahani N; Alladi PA; Vijayalakshmi K; Sathyaprabha TN; Nalini A; Ravi V; Raju TR
J Neural Transm (Vienna); 2011 Apr; 118(4):531-8. PubMed ID: 21069391
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS).
Cashman N; Tan LY; Krieger C; Mädler B; Mackay A; Mackenzie I; Benny B; Nantel S; Fabros M; Shinobu L; Yousefi M; Eisen A
Muscle Nerve; 2008 May; 37(5):620-5. PubMed ID: 18335482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
